• Here’s Why Cedar Fair (FUN) Stock is an Attractive Pick for Investors

    Here’s Why Cedar Fair (FUN) Stock is an Attractive Pick for InvestorsMiller Value Partners recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Miller Value Partners Opportunity Equity Fund posted a return of -38.4% for the quarter (net of fees), underperforming its benchmark, the S&P 500 Index which returned -19.6% in the same quarter. You should check out Miller […]

    from Yahoo Finance https://ift.tt/3dS8ILv

  • Bond Markets Have a Trillion Reasons to Brace for Super Thursday

    Bond Markets Have a Trillion Reasons to Brace for Super Thursday(Bloomberg) — After a record-breaking week with a market milestone reading one trillion euros, European investors are getting ready for a busy Thursday that could feature the same number.That’s when the European Central Bank will dish out cheap loans to banks, with take-up expected to reach the eye-catching amount. The ECB sweetened terms of its so-called TLTROs in April, in an effort to boost lending and further ease stress in Europe’s money markets.Such take-up would come soon after last Tuesday’s bond bonanza, when almost 32 billion euros ($36 billion) of sovereign debt was sold. It took Europe’s primary market issuance to over one trillion euros this year — a milestone passed 12 weeks faster than in 2019 — as governments rushed to fund their ever-increasing stimulus packages in an effort to avert the threat of economic depression from the coronavirus.Two other major monetary policy institutions also have Thursday announcements.The Bank of England is expected to announce an increase of 200 billion pounds to its bond-buying stimulus, taking it to 845 billion pounds, according to Citigroup Inc, given the BOE’s current round of ammunition will run out in July at the current pace of buying. Further out, the bank also sees policy makers easing rates to zero in November, with tentative cuts to sub-zero territory possible next year.The Swiss National Bank looks likely to buck the trend for largess by refraining from extending stimulus and keeping rates on hold.Political developments are also in prospect, with the European Union’s leaders meeting to discuss a 750-billion-euro recovery fund, in what could prove to be another landmark moment for the bloc’s response to the crisis.Also Next Week:Euro-area bond sales are scheduled from Germany, which will sell a new 10-year note, as well as France and Spain, and are set to total around 21 billion euros for the week, according to Commerzbank AG.Portugal may sell debt through banks as it will pay bond redemptions of 8 billion euros. Italy will also pay almost 16 billion euros of redemptions and make small coupon payments.The U.K. will hold four regular gilt auctions for a combined 11 billion pounds and buy back bonds at a steady rate of 1.5 billion pounds per operation.Data for the coming week in the euro area and Germany is mostly relegated to second-tier, backward-looking figures, with the exception of German ZEW survey figures for JuneThe U.K. data slate picks up with May inflation, retail sales and government borrowing numbers garnering most of the attention aside from the BOE announcementIgazio Visco on Tuesday is the sole ECB speaker scheduled next week; ECB publishes its economic bulletin ThursdayBOE Governor Andrew Bailey will not hold a press conference after Thursday’s interest-rate decision and there are no further policy makers scheduled to speakThere are no major sovereign rating reviews next FridayFor more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

    from Yahoo Finance https://ift.tt/2B8mJpG

  • You could beat the market in the 2020s with these ASX healthcare shares

    healthcare shares

    Over the last five years the healthcare sector has been one of the best performing areas of the share market.

    During this time the S&P/ASX 200 Health Care index has gained more than 125%. This has vastly outperformed the S&P/ASX 200 Index (ASX: XJO) which is only up 7.5% over the same period (excluding dividends).

    While I doubt this level of outperformance will continue over the next five years, I believe the healthcare sector is still very well-placed to beat the market.

    Especially given the increasing demand for healthcare services due to ageing populations, increased chronic disease burden, and product and technological developments.

    In light of this, I think having exposure to the healthcare sector would be a very smart move. Here are two ASX healthcare shares that I would buy:

    CSL Limited (ASX: CSL)

    The first healthcare share to consider buying is CSL. It is one of the world’s leading biotherapeutics companies and has a portfolio of life-saving therapies and vaccines. In addition to this, CSL invests heavily in research and development. This investment means it has a large number of therapies in its pipeline that have the potential to generates significant sales over the next decade. Combined, I believe CSL is well-positioned to continue growing its earnings at a solid rate throughout the 2020s.

    ResMed Inc. (ASX: RMD)

    Another healthcare share to consider buying is ResMed. It was a very strong performer over the 2010s and I feel confident it can repeat this throughout the 2020s. This is due to the medical device company’s focus on the sleep treatment market. The proliferation of obstructive sleep apnoea is driving increasing demand for masks and software solutions. Given the quality of its offering and its wide distribution network, I believe it is well-placed to capture this growing demand and deliver strong earnings growth this decade.

    And named below are more top shares which I think could beat the market over the next decade…

    5 stocks under $5

    We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

    And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $5 a share!

    *Extreme Opportunities returns as of June 5th 2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post You could beat the market in the 2020s with these ASX healthcare shares appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/37BNuzn

Sorry, but nothing was found. Please try a search with different keywords.